Latest Organofluorides Stories
The Firm is representing numerous Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New
-- CHOP and Penn Medicine Experts Define Riskier Mutations in Neuroblastoma, Setting Stage for Clinical Trial-- PHILADELPHIA, Nov.
The Firm is representing numerous plaintiffs who have filed Risperdal gynecomastia lawsuits in the Philadelphia Court of Common Pleas. New York, NY (PRWEB) November
Asia-Pacific Polytetrafluoroethylene (PTFE) market to grow at a CAGR of 8.3% from 2013 to 2018, driven by huge investments from manufacturing companies in end-user industries
The Firm is representing numerous Risperdal plaintiffs who have filed claims in Pennsylvania that allege the atypical antipsychotic medication caused the development of gynecomastia, or male breast
North American Polytetrafluoroethylene market to reach $489.7 million by 2018 at a CAGR of 4.6% from 2013 to 2018, driven by huge investments in innovation and technology
The Firm is representing numerous plaintiffs who have filed Risperdal gynecomastia lawsuits in the Pennsylvania litigation. New York, NY (PRWEB) November 05,
European Polytetrafluoroethylene (PTFE) market to reach $603.8 million by 2018 at a CAGR of 5.5% from 2013 to 2018, driven by massive investments from end-user industries of PTFE
The first Risperdal lawsuits trails alleging the anti-psychotic drug caused gynecomastia or enlarged male breasts begin today In Philadelphia. Columbus, OH (PRWEB)
NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.